InsidersTradesSigma
팬젠 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 팬젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 팬젠 has recorded 4 reports. Market capitalisation: €65.3bn. The latest transaction was filed on 24 April 2026 (Sale). Among the most active insiders: 오한규. The full history is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
4 ops.
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,736 of 27,807 companies
52.4
score / 100
Value38
Quality67
FCF yld-0.8%
Earn yld3.1%
EV/EBITDA18.0x
ROE7.3%
Gross mgn34%
Net mgn15%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 April 2026
About 팬젠
팬젠 is a company in the health and pharmaceutical sector listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.